The findings could pave the way for new strategies to prevent colorectal cancer. Previous research indicated that BFT disrupts the protective lining of the colon and fosters persistent inflammation, which is a known risk factor for cancer development. Without claudin-4, BFT cannot latch onto colon cells or cause harm. If successful, such drugs could prevent conditions linked to this toxin, including bowel inflammation and colorectal cancer. If you’re interested in cancer prevention, consider reading about studies linking artificial sweeteners to increased cancer risk, or how drinking milk might influence heart disease and cancer risks.